Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Papilloma, Squamous Cell

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Papilloma, Squamous Cell in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battalora, MS1
Johnston, DA1
DiGiovanni, J1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Papilloma, Squamous Cell

ArticleYear
The effects of calcium antagonists on anthrone skin tumor promotion and promoter-related effects in SENCAR mice.
    Cancer letters, 1995, Nov-27, Volume: 98, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthracenes; Calcium; Calcium Channel Blockers; Carcinoge

1995